Patents Assigned to Hemogen, Inc.
  • Vitamin B12 containing scalp and skin treatment compositions
    Patent number: 6110472
    Abstract: The invention teaches compositions useful for treating conditions characterized by excess exfoliation or hyperkeratinization, such as dandruff. These compositions include vitamin B12 in an amount sufficient to alleviate exfoliation. Dandruff is one condition which may be treated using the formulations.
    Type: Grant
    Filed: August 4, 1994
    Date of Patent: August 29, 2000
    Assignee: Hemogen Inc.
    Inventors: Richard D. Levere, Nadar G. Abraham, Michal L. Schwartzman, Michael W. Dunn
  • Method for treating non-ocular epithelial disorders via increasing heme oxygenase levels and/or decreasing levels of arachidonic acid derivatives
    Patent number: 5783201
    Abstract: Vitamin B12 is used to stimulate heme oxygenase production. In turn, levels of the molecules 12(R)-HETE and 12(R)-DIHETE, which are arachidonic acid derivatives, are reduced. Various topical formulations containing vitamin B12, but no other vitamins, are described.
    Type: Grant
    Filed: April 3, 1997
    Date of Patent: July 21, 1998
    Assignee: Hemogen, Inc.
    Inventors: Richard D. Levere, Nadar G. Abraham, Michal L. Schwartzman, Michael W. Dunn
  • Method for treating non-ocular epithelial disorders via increasing heme oxygenase levels and/or decreasing levels of arachidonic acid derivatives
    Patent number: 5674505
    Abstract: Vitamin B12 is used to stimulate heme oxygenase production. In turn, levels of the molecules 12(R)-HETE and 12(R)-DIHETE, which are arachidonic acid derivatives, are reduced. Various topical formulations containing vitamin B12, but no other vitamins, are described.
    Type: Grant
    Filed: August 2, 1994
    Date of Patent: October 7, 1997
    Assignee: Hemogen, Inc.
    Inventors: Richard D. Levere, Nadar G. Abraham, Michal L. Schwartzman, Michael W. Dunn